5 Types of Pitch Decks And How To Choose The Right One

pitch deck types

A pitch deck isn’t “a deck.” It’s a decision surface—a compressed view of a business idea that lets a specific evaluator decide what happens next. When people call a deck “weak,” they usually mean “it doesn’t match the evaluation context,” not that the slides are ugly. This is why different types of business pitches matter. … Read more

Pitch Deck vs Pitch Book: Investor Guide to Key Differences

pitch deck vs pitch book

Choosing between a pitch deck vs pitchbook matters because each format reflects a different evaluation environment. One is built for fast pattern recognition (people scanning for the “shape” of a story). The other is built for documentation (people checking assumptions, numbers, and deal logic).  A pitch deck is a short, story-driven investor presentation—a visual presentation … Read more

How Much Does An Investor Ready Pitch Deck Cost?

How much does a pitch deck cost

Pitch deck cost refers to the total cost of creating a pitch deck (the full deck, not just “nice slides”) that communicates a business opportunity clearly in a decision environment. That includes pitch deck design, story and structure work, visual hierarchy, and revisions—everything required for a professional pitch deck that holds together when a potential … Read more

Reasons Why Investors Say No to Your Startup

reasons why investors say no

When an investor says “no,” it rarely means your startup is worthless. It usually means: “given my fund, my thesis, my portfolio, and the risks I’m paid to absorb, I can’t justify an investment right now.” That distinction matters, because founders hear a moral judgment where the investor is making a portfolio decision.  A rejection … Read more

The 10 20 30 Rule in Pitch Decks By Guy Kawasaki

10 20 30 rule in pitch decks

The 10-20-30 Rule — popularized by Guy Kawasaki — offers a framing shortcut for pitch presentations under pressure. It proposes a format of 10 slides, delivered in 20 minutes, using 30-point font. Originally crafted for venture pitch contexts, it has since become a design philosophy for any scenario where cognitive load and time constraints matter. … Read more

Asset & Fund Capital Evaluation: How Institutional Capital Assesses Allocation Risk

Institutional capital evaluates asset and fund vehicles through an allocation lens, not a narrative one. This page explains how allocators, investment committees, and fiduciaries assess eligibility, diversification integrity, and portfolio fit within asset and fund capital structures. It applies the universal capital decision logic established in Hub 1, without redefining it. This is not execution … Read more

Industrial / Infrastructure Capital Evaluation: How Institutional Capital Assesses Investment Eligibility

This page explains how institutional capital evaluates industrial and infrastructure investment eligibility through a sector-specific lens. It applies the universal capital decision logic already established at the institutional level, and shows how that logic expresses itself when reviewing infrastructure assets, infrastructure projects, and long-duration physical systems. This is not execution guidance, not a guide to … Read more

Consumer Brand Capital Evaluation: How Institutional Capital Assesses Brand Equity

Consumer brand capital evaluation is not about taste, creativity, or cultural relevance. It is about whether brand equity functions as a defensible capital asset—one that stabilizes cash flow, sustains margins, and reduces downside risk across cycles. This page explains how institutional capital evaluates consumer brands through that lens. It applies the universal capital decision logic … Read more

Enterprise / B2B Software Capital Evaluation: How Institutional Capital Assesses Valuation Risk

This page explains how institutional capital evaluates Enterprise and B2B software companies through a sector-specific risk lens. It applies the universal capital decision logic already established at the institutional level, and shows how that logic manifests when reviewing B2B SaaS and enterprise software businesses. This is not execution guidance. It does not explain how to … Read more

Healthcare & Life Sciences Capital Evaluation: How Institutional Capital Assesses Risk

Institutional capital evaluates healthcare and life sciences through a sector-specific risk lens shaped by regulation, clinical uncertainty, reimbursement dependency, and long-duration capital exposure. This page explains how evaluators apply those constraints when reviewing eligibility and downside containment in healthcare and life sciences investments. It does not explain execution, pitching, or capital raising mechanics. Universal capital … Read more